Advertisement

Index by Author

February 1991; 40 (2)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

B

  1. Bailbe, D

    • Impairment of glycerol phosphate shuttle in islets from rats with diabetes induced by neonatal streptozocin. Diabetes February 1991 40:227-232; doi:10.2337/diabetes.40.2.227

  2. Baynes, J W

    • Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes February 1991 40:190-196; doi:10.2337/diabetes.40.2.190

  3. Bellush, L L

    • Altered behavior and neurochemistry during short-term insulin withdrawal in streptozocin-induced diabetic rats. Diabetes February 1991 40:217-222; doi:10.2337/diabetes.40.2.217

  4. Bendtzen, K

    • Influence of protease on inhibitory and stimulatory effects of interleukin 1 beta on beta-cell function. Diabetes February 1991 40:290-294; doi:10.2337/diabetes.40.2.290

  5. Boner, G

    • Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes February 1991 40:204-210; doi:10.2337/diabetes.40.2.204

  6. Butler, L

    • Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/Wor rats. Diabetes February 1991 40:259-262; doi:10.2337/diabetes.40.2.259

C

  1. Castell, J V

    • Role of glucose, insulin, and glucagon in glycogen mobilization in human hepatocytes. Diabetes February 1991 40:263-268; doi:10.2337/diabetes.40.2.263

  2. Chen, Y D

    • Production of inhibitor of insulin-receptor tyrosine kinase in fibroblasts from patient with insulin resistance and NIDDM. Diabetes February 1991 40:295-299; doi:10.2337/diabetes.40.2.295

  3. Chisholm, D J

    • Effects of exercise training and dietary manipulation on insulin-regulatable glucose-transporter mRNA in rat muscle. Diabetes February 1991 40:275-279; doi:10.2337/diabetes.40.2.275
    • Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes February 1991 40:280-289; doi:10.2337/diabetes.40.2.280

  4. Ciavatti, M

    • Effects of PP-56 and vitamin E on platelet hyperaggregability, fatty acid abnormalities, and clinical manifestations in streptozocin-induced diabetic rats. Diabetes February 1991 40:233-239; doi:10.2337/diabetes.40.2.233

  5. Clark, P W

    • Effects of exercise training and dietary manipulation on insulin-regulatable glucose-transporter mRNA in rat muscle. Diabetes February 1991 40:275-279; doi:10.2337/diabetes.40.2.275

  6. Collier, E

    • O-linked oligosaccharides on insulin receptor. Diabetes February 1991 40:197-203; doi:10.2337/diabetes.40.2.197

  7. Cryer, P E

    • Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes February 1991 40:223-226; doi:10.2337/diabetes.40.2.223

D

  1. Dunlap, J A

    • Restoration of Na(+)-K+ pump activity and resting membrane potential by myo-inositol supplementation in neuroblastoma cells chronically exposed to glucose or galactose. Diabetes February 1991 40:240-248; doi:10.2337/diabetes.40.2.240

  2. Dunn, J A

    • Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes February 1991 40:190-196; doi:10.2337/diabetes.40.2.190

E

  1. Erman, A

    • Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes February 1991 40:204-210; doi:10.2337/diabetes.40.2.204

G

  1. Giroix, M H

    • Impairment of glycerol phosphate shuttle in islets from rats with diabetes induced by neonatal streptozocin. Diabetes February 1991 40:227-232; doi:10.2337/diabetes.40.2.227

  2. Goldfine, I D

    • Archaeology of NIDDM. Excavation of the "thrifty" genotype. Diabetes February 1991 40:161-165; doi:10.2337/diabetes.40.2.161
    • Production of inhibitor of insulin-receptor tyrosine kinase in fibroblasts from patient with insulin resistance and NIDDM. Diabetes February 1991 40:295-299; doi:10.2337/diabetes.40.2.295

  3. Gómez-Lechón, M J

    • Role of glucose, insulin, and glucagon in glycogen mobilization in human hepatocytes. Diabetes February 1991 40:263-268; doi:10.2337/diabetes.40.2.263

  4. Goodman, P A

    • Production of inhibitor of insulin-receptor tyrosine kinase in fibroblasts from patient with insulin resistance and NIDDM. Diabetes February 1991 40:295-299; doi:10.2337/diabetes.40.2.295

  5. Gorden, P

    • O-linked oligosaccharides on insulin receptor. Diabetes February 1991 40:197-203; doi:10.2337/diabetes.40.2.197

  6. Greiner, D L

    • Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. Diabetes February 1991 40:255-258; doi:10.2337/diabetes.40.2.255

  7. Guberski, D L

    • Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/Wor rats. Diabetes February 1991 40:259-262; doi:10.2337/diabetes.40.2.259

  8. Gustafsson, T

    • Effects of PP-56 and vitamin E on platelet hyperaggregability, fatty acid abnormalities, and clinical manifestations in streptozocin-induced diabetic rats. Diabetes February 1991 40:233-239; doi:10.2337/diabetes.40.2.233

H

  1. Handler, E S

    • Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. Diabetes February 1991 40:255-258; doi:10.2337/diabetes.40.2.255

  2. Hayes, G R

    • Intermolecular phosphorylation of insulin receptor as possible mechanism for amplification of binding signal. Diabetes February 1991 40:300-303; doi:10.2337/diabetes.40.2.300

  3. Heller, S R

    • Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes February 1991 40:223-226; doi:10.2337/diabetes.40.2.223

  4. Honour, J

    • Decreased growth velocity before IDDM onset. Diabetes February 1991 40:211-216; doi:10.2337/diabetes.40.2.211

I

  1. Ihm, S H

    • Studies on autoimmunity for initiation of beta-cell destruction. VII. Evidence for antigenic changes on beta-cells leading to autoimmune destruction of beta-cells in BB rats. Diabetes February 1991 40:269-274; doi:10.2337/diabetes.40.2.269

J

  1. James, D E

    • Effects of exercise training and dietary manipulation on insulin-regulatable glucose-transporter mRNA in rat muscle. Diabetes February 1991 40:275-279; doi:10.2337/diabetes.40.2.275

  2. Jenkins, A B

    • Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes February 1991 40:280-289; doi:10.2337/diabetes.40.2.280

K

  1. Kalter-Leibovici, O

    • Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes February 1991 40:204-210; doi:10.2337/diabetes.40.2.204

  2. Karp, M

    • Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes February 1991 40:204-210; doi:10.2337/diabetes.40.2.204

  3. Khouri, S

    • Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes February 1991 40:280-289; doi:10.2337/diabetes.40.2.280

  4. Knecht, K J

    • Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes February 1991 40:190-196; doi:10.2337/diabetes.40.2.190

  5. Kraegen, E W

    • Effects of exercise training and dietary manipulation on insulin-regulatable glucose-transporter mRNA in rat muscle. Diabetes February 1991 40:275-279; doi:10.2337/diabetes.40.2.275
    • Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes February 1991 40:280-289; doi:10.2337/diabetes.40.2.280

  6. Kremer, I

    • Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes February 1991 40:204-210; doi:10.2337/diabetes.40.2.204

  7. Kusari, J

    • Insulin-receptor cDNA sequence in NIDDM patient homozygous for insulin-receptor gene RFLP. Diabetes February 1991 40:249-254; doi:10.2337/diabetes.40.2.249

L

  1. Laron, Z

    • Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes February 1991 40:204-210; doi:10.2337/diabetes.40.2.204

  2. Leclercq-Meyer, V

    • Impairment of glycerol phosphate shuttle in islets from rats with diabetes induced by neonatal streptozocin. Diabetes February 1991 40:227-232; doi:10.2337/diabetes.40.2.227

  3. Lee, K U

    • Studies on autoimmunity for initiation of beta-cell destruction. VII. Evidence for antigenic changes on beta-cells leading to autoimmune destruction of beta-cells in BB rats. Diabetes February 1991 40:269-274; doi:10.2337/diabetes.40.2.269

  4. Leibovici, L

    • Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes February 1991 40:204-210; doi:10.2337/diabetes.40.2.204

  5. Leslie, R D

    • Decreased growth velocity before IDDM onset. Diabetes February 1991 40:211-216; doi:10.2337/diabetes.40.2.211

  6. Like, A A

    • Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/Wor rats. Diabetes February 1991 40:259-262; doi:10.2337/diabetes.40.2.259

  7. Lockwood, D H

    • Intermolecular phosphorylation of insulin receptor as possible mechanism for amplification of binding signal. Diabetes February 1991 40:300-303; doi:10.2337/diabetes.40.2.300

  8. Lo, S

    • Decreased growth velocity before IDDM onset. Diabetes February 1991 40:211-216; doi:10.2337/diabetes.40.2.211

  9. Loya, N

    • Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes February 1991 40:204-210; doi:10.2337/diabetes.40.2.204

  10. Lydon, L D

    • Intermolecular phosphorylation of insulin receptor as possible mechanism for amplification of binding signal. Diabetes February 1991 40:300-303; doi:10.2337/diabetes.40.2.300

  11. Lyons, T J

    • Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes February 1991 40:190-196; doi:10.2337/diabetes.40.2.190

M

  1. Maddux, B A

    • Production of inhibitor of insulin-receptor tyrosine kinase in fibroblasts from patient with insulin resistance and NIDDM. Diabetes February 1991 40:295-299; doi:10.2337/diabetes.40.2.295

  2. Malaisse, W J

    • Impairment of glycerol phosphate shuttle in islets from rats with diabetes induced by neonatal streptozocin. Diabetes February 1991 40:227-232; doi:10.2337/diabetes.40.2.227

  3. McCance, D R

    • Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes February 1991 40:190-196; doi:10.2337/diabetes.40.2.190

  4. McClain, D A

    • Insulin-receptor cDNA sequence in NIDDM patient homozygous for insulin-receptor gene RFLP. Diabetes February 1991 40:249-254; doi:10.2337/diabetes.40.2.249

  5. McFarland, K F

    • Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes February 1991 40:190-196; doi:10.2337/diabetes.40.2.190

  6. Millward, B A

    • Decreased growth velocity before IDDM onset. Diabetes February 1991 40:211-216; doi:10.2337/diabetes.40.2.211

  7. Mordes, J P

    • Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. Diabetes February 1991 40:255-258; doi:10.2337/diabetes.40.2.255

O

  1. Olefsky, J M

    • Insulin-receptor cDNA sequence in NIDDM patient homozygous for insulin-receptor gene RFLP. Diabetes February 1991 40:249-254; doi:10.2337/diabetes.40.2.249

  2. Orland, M J

    • Comparative modulations of insulin secretion, pancreatic insulin content, and proinsulin mRNA in rats. Effects of 50% pancreatectomy and dexamethasone administration. Diabetes February 1991 40:181-189; doi:10.2337/diabetes.40.2.181

P

  1. Pascoe, W S

    • Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes February 1991 40:280-289; doi:10.2337/diabetes.40.2.280

  2. Permutt, M A

    • Comparative modulations of insulin secretion, pancreatic insulin content, and proinsulin mRNA in rats. Effects of 50% pancreatectomy and dexamethasone administration. Diabetes February 1991 40:181-189; doi:10.2337/diabetes.40.2.181

  3. Pilar López, M

    • Role of glucose, insulin, and glucagon in glycogen mobilization in human hepatocytes. Diabetes February 1991 40:263-268; doi:10.2337/diabetes.40.2.263

  4. Porte, D, Jr

    • Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes February 1991 40:166-180; doi:10.2337/diabetes.40.2.166

  5. Portha, B

    • Impairment of glycerol phosphate shuttle in islets from rats with diabetes induced by neonatal streptozocin. Diabetes February 1991 40:227-232; doi:10.2337/diabetes.40.2.227

  6. Pyke, D A

    • Decreased growth velocity before IDDM onset. Diabetes February 1991 40:211-216; doi:10.2337/diabetes.40.2.211

R

  1. Rasschaert, J

    • Impairment of glycerol phosphate shuttle in islets from rats with diabetes induced by neonatal streptozocin. Diabetes February 1991 40:227-232; doi:10.2337/diabetes.40.2.227

  2. Reaven, G M

    • Production of inhibitor of insulin-receptor tyrosine kinase in fibroblasts from patient with insulin resistance and NIDDM. Diabetes February 1991 40:295-299; doi:10.2337/diabetes.40.2.295

  3. Reid, S G

    • Altered behavior and neurochemistry during short-term insulin withdrawal in streptozocin-induced diabetic rats. Diabetes February 1991 40:217-222; doi:10.2337/diabetes.40.2.217

  4. Renaud, S

    • Effects of PP-56 and vitamin E on platelet hyperaggregability, fatty acid abnormalities, and clinical manifestations in streptozocin-induced diabetic rats. Diabetes February 1991 40:233-239; doi:10.2337/diabetes.40.2.233

  5. Rosenfeld, J B

    • Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes February 1991 40:204-210; doi:10.2337/diabetes.40.2.204

  6. Rossini, A A

    • Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. Diabetes February 1991 40:255-258; doi:10.2337/diabetes.40.2.255

  7. Ruf, J C

    • Effects of PP-56 and vitamin E on platelet hyperaggregability, fatty acid abnormalities, and clinical manifestations in streptozocin-induced diabetic rats. Diabetes February 1991 40:233-239; doi:10.2337/diabetes.40.2.233

S

  1. Sandler, S

    • Influence of protease on inhibitory and stimulatory effects of interleukin 1 beta on beta-cell function. Diabetes February 1991 40:290-294; doi:10.2337/diabetes.40.2.290

  2. Sbraccia, P

    • Production of inhibitor of insulin-receptor tyrosine kinase in fibroblasts from patient with insulin resistance and NIDDM. Diabetes February 1991 40:295-299; doi:10.2337/diabetes.40.2.295

  3. Sener, A

    • Impairment of glycerol phosphate shuttle in islets from rats with diabetes induced by neonatal streptozocin. Diabetes February 1991 40:227-232; doi:10.2337/diabetes.40.2.227

  4. Shine, J

    • Effects of exercise training and dietary manipulation on insulin-regulatable glucose-transporter mRNA in rat muscle. Diabetes February 1991 40:275-279; doi:10.2337/diabetes.40.2.275

  5. Sowden, J A

    • Effects of exercise training and dietary manipulation on insulin-regulatable glucose-transporter mRNA in rat muscle. Diabetes February 1991 40:275-279; doi:10.2337/diabetes.40.2.275

  6. Stefani, M R

    • Restoration of Na(+)-K+ pump activity and resting membrane potential by myo-inositol supplementation in neuroblastoma cells chronically exposed to glucose or galactose. Diabetes February 1991 40:240-248; doi:10.2337/diabetes.40.2.240

  7. Storlien, L H

    • Effects of exercise training and dietary manipulation on insulin-regulatable glucose-transporter mRNA in rat muscle. Diabetes February 1991 40:275-279; doi:10.2337/diabetes.40.2.275
    • Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes February 1991 40:280-289; doi:10.2337/diabetes.40.2.280

  8. Strahl, C

    • Insulin-receptor cDNA sequence in NIDDM patient homozygous for insulin-receptor gene RFLP. Diabetes February 1991 40:249-254; doi:10.2337/diabetes.40.2.249

T

  1. Thomas, V A

    • Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. Diabetes February 1991 40:255-258; doi:10.2337/diabetes.40.2.255

  2. Thorpe, S R

    • Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes February 1991 40:190-196; doi:10.2337/diabetes.40.2.190

V

  1. Van Dyk, D J

    • Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes February 1991 40:204-210; doi:10.2337/diabetes.40.2.204

W

  1. Wake, S A

    • Effects of exercise training and dietary manipulation on insulin-regulatable glucose-transporter mRNA in rat muscle. Diabetes February 1991 40:275-279; doi:10.2337/diabetes.40.2.275

  2. Welsh, N

    • Influence of protease on inhibitory and stimulatory effects of interleukin 1 beta on beta-cell function. Diabetes February 1991 40:290-294; doi:10.2337/diabetes.40.2.290

  3. Wendorf, M

    • Archaeology of NIDDM. Excavation of the "thrifty" genotype. Diabetes February 1991 40:161-165; doi:10.2337/diabetes.40.2.161

  4. Woda, B A

    • Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. Diabetes February 1991 40:255-258; doi:10.2337/diabetes.40.2.255

  5. Wong, K Y

    • Production of inhibitor of insulin-receptor tyrosine kinase in fibroblasts from patient with insulin resistance and NIDDM. Diabetes February 1991 40:295-299; doi:10.2337/diabetes.40.2.295

Y

  1. Yoon, J W

    • Studies on autoimmunity for initiation of beta-cell destruction. VII. Evidence for antigenic changes on beta-cells leading to autoimmune destruction of beta-cells in BB rats. Diabetes February 1991 40:269-274; doi:10.2337/diabetes.40.2.269

  2. Yorek, M A

    • Restoration of Na(+)-K+ pump activity and resting membrane potential by myo-inositol supplementation in neuroblastoma cells chronically exposed to glucose or galactose. Diabetes February 1991 40:240-248; doi:10.2337/diabetes.40.2.240

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement